These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1208 related items for PubMed ID: 17896145

  • 1. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
    Boige V, Malka D, Elias D, Castaing M, De Baere T, Goere D, Dromain C, Pocard M, Ducreux M.
    Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
    [Abstract] [Full Text] [Related]

  • 2. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
    Ducreux M, Ychou M, Laplanche A, Gamelin E, Lasser P, Husseini F, Quenet F, Viret F, Jacob JH, Boige V, Elias D, Delperro JR, Luboinski M, gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
    J Clin Oncol; 2005 Aug 01; 23(22):4881-7. PubMed ID: 16009952
    [Abstract] [Full Text] [Related]

  • 3. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H, Ozaki T, Shiina M.
    Cardiovasc Intervent Radiol; 2009 Jul 01; 32(4):679-86. PubMed ID: 19296157
    [Abstract] [Full Text] [Related]

  • 4. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases.
    Goéré D, Deshaies I, de Baere T, Boige V, Malka D, Dumont F, Dromain C, Ducreux M, Elias D.
    Ann Surg; 2010 Apr 01; 251(4):686-91. PubMed ID: 20224373
    [Abstract] [Full Text] [Related]

  • 5. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.
    Samaras P, Breitenstein S, Haile SR, Stenner-Liewen F, Heinrich S, Feilchenfeldt J, Renner C, Knuth A, Pestalozzi BC, Clavien PA.
    Ann Surg Oncol; 2011 Jul 01; 18(7):1924-31. PubMed ID: 21207165
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
    Del Freo A, Fiorentini G, Sanguinetti F, Muttini MP, Pennucci C, Mambrini A, Pacetti P, Della Seta R, Lombardi M, Torri T, Cantore M.
    In Vivo; 2006 Jul 01; 20(6A):743-6. PubMed ID: 17203759
    [Abstract] [Full Text] [Related]

  • 11. Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases.
    Neyns B, Van Nieuwenhove Y, Aerts M, Fontaine C, Vermeij J, Schallier D, Decoster L, De Mey J, Vandenbroucke F, Hoorens A, Delvaux G, De Gréve J.
    Anticancer Res; 2006 Jul 01; 26(1B):611-9. PubMed ID: 16739329
    [Abstract] [Full Text] [Related]

  • 12. Raltitrexed and oxaliplatin hepatic arterial infusion for advanced colorectal cancer: a retrospective study.
    Khouri C, Guiu B, Cercueil JP, Chauffert B, Ladoire S, Ghiringhelli F.
    Anticancer Drugs; 2010 Jul 01; 21(6):656-61. PubMed ID: 20216061
    [Abstract] [Full Text] [Related]

  • 13. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
    Guan M, Chen SC, Ying HY, Zhao L, Li XY, Zhou JF, Shao YJ, Yang XD, Lin Y, Ning XH, Bai CM.
    Chin Med J (Engl); 2012 Oct 01; 125(20):3640-5. PubMed ID: 23075717
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
    Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, Bertino JR, Turnbull AD, Sullivan D, Stockman J, Blumgart LH, Fong Y.
    N Engl J Med; 1999 Dec 30; 341(27):2039-48. PubMed ID: 10615075
    [Abstract] [Full Text] [Related]

  • 17. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study.
    Alberts SR, Horvath WL, Sternfeld WC, Goldberg RM, Mahoney MR, Dakhil SR, Levitt R, Rowland K, Nair S, Sargent DJ, Donohue JH.
    J Clin Oncol; 2005 Dec 20; 23(36):9243-9. PubMed ID: 16230673
    [Abstract] [Full Text] [Related]

  • 18. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies.
    Lorenz M, Staib-Sebler E, Gog C, Proschek D, Jauch KW, Ridwelski K, Hohenberger W, Gassel HJ, Lehmann U, Vestweber KH, Padberg W, Zamzow K, Müller HH.
    Zentralbl Chir; 2003 Feb 20; 128(2):87-94. PubMed ID: 12632273
    [Abstract] [Full Text] [Related]

  • 19. A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies.
    Viel E, Demarchi MF, Chaigneau L, Nguyen T, Legat C, Stein U, Thiery-Vuillemin A, Limat S, Pivot X, Borg C.
    Am J Clin Oncol; 2008 Feb 20; 31(1):89-94. PubMed ID: 18376234
    [Abstract] [Full Text] [Related]

  • 20. [Hepatic arterial infusion of low-dose leucovorin/5-FU chemotherapy for unresectable hepatic metastases from colorectal cancer].
    Fujimoto T, Yoshimatsu K, Yokomizo H, Umehara A, Watanabe K, Ohtani T, Matsumoto A, Ohsawa G, Ishibashi K, Ogawa K.
    Gan To Kagaku Ryoho; 2006 Nov 20; 33(12):1838-40. PubMed ID: 17212122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.